tetano
Editor, Senior Moderator
Infect Control Hosp Epidemiol
. 2023 Apr 20;1-3.
doi: 10.1017/ice.2023.71. Online ahead of print.
National survey study of nirmatrelvir-ritonavir prescribing processes and access barriers during the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron surge of the coronavirus disease 2019 (COVID-19) pandemic
Rebecca Wang[SUP] 1 [/SUP], Michael S Calderwood[SUP] 1 [/SUP], Craig P Worby[SUP] 2 [/SUP], Jose R Mercado[SUP] 3 [/SUP], Justin J Kim[SUP] 1 [/SUP]
Affiliations
Abstract
In this national survey, we found that individual patient assessments by pharmacists were more common at facilities using centralized prescribing for nirmetralvir-ritonavir (Paxlovid) than decentralized prescribing. Provider discomfort was initially less with centralized prescribing, but later, there was no difference in provider discomfort based on prescribing mechanism.
. 2023 Apr 20;1-3.
doi: 10.1017/ice.2023.71. Online ahead of print.
National survey study of nirmatrelvir-ritonavir prescribing processes and access barriers during the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron surge of the coronavirus disease 2019 (COVID-19) pandemic
Rebecca Wang[SUP] 1 [/SUP], Michael S Calderwood[SUP] 1 [/SUP], Craig P Worby[SUP] 2 [/SUP], Jose R Mercado[SUP] 3 [/SUP], Justin J Kim[SUP] 1 [/SUP]
Affiliations
- PMID: 37078462
- DOI: 10.1017/ice.2023.71
Abstract
In this national survey, we found that individual patient assessments by pharmacists were more common at facilities using centralized prescribing for nirmetralvir-ritonavir (Paxlovid) than decentralized prescribing. Provider discomfort was initially less with centralized prescribing, but later, there was no difference in provider discomfort based on prescribing mechanism.